Toggle light / dark theme

Zap-and-freeze’ technique used to watch human brain cell communication

For the new study, the researchers used samples from the brains of normal mice as well as living cortical brain tissue sampled with permission from six individuals undergoing surgical treatment for epilepsy. The surgical procedures were medically necessary to remove lesions from the brain’s hippocampus.

The researchers first validated the zap-and-freeze approach by observing calcium signaling, a process that triggers neurons to release neurotransmitters in living mouse brain tissues.

Next, the scientists stimulated neurons in mouse brain tissue with the zap-and-freeze approach and observed where synaptic vesicles fuse with brain cell membranes and then release chemicals called neurotransmitters that reach other brain cells. The scientists then observed how mouse brain cells recycle synaptic vesicles after they are used for neuronal communication, a process known as endocytosis that allows material to be taken up by neurons.

The researchers then applied the zap-and-freeze technique to brain tissue samples from people with epilepsy, and observed the same synaptic vesicle recycling pathway operating in human neurons.

In both mouse and human brain samples, the protein Dynamin1xA, which is essential for ultrafast synaptic membrane recycling, was present where endocytosis is thought to occur on the membrane of the synapse.

“Our findings indicate that the molecular mechanism of ultrafast endocytosis is conserved between mice and human brain tissues,” the author says, suggesting that the investigations in these models are valuable for understanding human biology.


Platelet-inspired nanoparticles can boost brain-computer interface electrode performance

Scientists working to enhance brain-computer interface (BCI) technology—which allows people to control devices with their thoughts—have found they can improve the performance of electrodes implanted in the brain by targeted delivery of anti-inflammatory drugs.

V-STARS pioneers neuroscience at ESA’s Orbital Robotics Lab

As part of the ESA Academy Experiments Programme, Team V-STARS carried out the first experiment with human participants in the Orbital Robotics Lab, investigating how microgravity affects the perception of verticality.

The V-STARS team, a collaboration between Birkbeck, University of London, and the University of Kent (UK), was selected to join the ESA Academy Experiments Programme in February 2025. After obtaining ethical approval from the United Kingdom and authorisation from the ESA Medical Board, the team was permitted to carry out their experiment in the Orbital Robotics Lab (ORL), located at ESTEC, the ESA site in the Netherlands.

The campaign involved test subjects seated on the ORL’s floating platform, wearing VR headsets while performing gravity-related perceptual tasks. The project investigates the use of Vestibular Stochastic Resonance — a phenomenon in which controlled noise enhances the sensitivity of a sensory system — to improve perception and potentially accelerate adaptation to microgravity. Over two weeks, the team tested more than 20 participants and has now returned to their universities to analyse the results.

Video NeuroImage: Stereotypic Motor Behaviors in a Patient With Pantothenate Kinase–Associated Neurodegeneration

A 24-year-old woman with pantothenate kinase–associated neurodegeneration (PKAN) presented with a 5-year history of psychiatric symptoms followed by prominent stereotypic motor behaviors, including repetitive touching of her mouth and leg, object manipulation, and tip-toe walking (Video 1). Examination revealed severe depression and anxiety, mild speech dysfluency, and the stereotypic movements. Previous symptomatic treatments provided limited benefit. Brain magnetic resonance imaging demonstrated the pathognomonic “eye-of-the-tiger” sign, indicative of iron deposition in the bilateral globus pallidus (Figure). Genetic testing identified compound heterozygous variants in the PANK2 gene: a known pathogenic variant (c.401AG) and a novel likely pathogenic variant (c.1465CG).

/* */